◆英語タイトル:Olink Proteomics AB - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011300
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月22日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Olink Proteomics AB (Olink) is a biotechnology company that provides products and services for human protein biomarker research. The company’s portfolio of products includes biomarkers, cardiovascular diseases panels, neurological disease panels, inflammation panels and oncology panels. Olink through its Proximity Extension Assay (PEA) technology develops multiplex immunoassay panels for human protein biomarker research. It works in collaboration with other organizations to develop new projects. The company through Olink Bioscience focuses on the development and commercialization of enabling molecular tools for life science research and molecular diagnostics. It also offers protein biomarker discovery data analysis services in Watertown and Sweden. The company also has operational presence in the US. Olink is headquartered in Uppsala, Sweden.
Olink Proteomics AB – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Olink Proteomics AB, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Olink Proteomics AB, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Olink Proteomics AB, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Olink Proteomics AB, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Olink Proteomics AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Olink Proteomics AB, Medical Equipment, Deal Details 10
Venture Financing 10
Olink Secures Venture Financing 10
Partnerships 11
Fluidigm Enters Into Co-Marketing Agreement With Olink Bioscience For Protein Biomarkers 11
Sigma Life Science Enters Into Distribution Agreement With Olink Bioscience For Duolink Technology 13
Olink Bioscience Enters Into Distribution Agreement With Bethyl Labs 14
Asset Transactions 15
Sigma-Aldrich Acquires Duolink Product Portfolio from Olink Bioscience 15
Olink Proteomics AB – Key Competitors 16
Olink Proteomics AB – Key Employees 17
Olink Proteomics AB – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Strategy And Business Planning 19
Apr 12, 2016: Focusing for success: A new Olink company organization to meet our future ambitions 19
Product News 20
Dec 14, 2017: Olink Proteomics announces the availability of the most comprehensive, high-multiplex protein biomarker panel for mouse studies 20
Feb 16, 2017: Olink Proteomics announces the availability of three new biomarker panels focused on key biological processes with broad clinical relevance 21
Nov 29, 2016: Olink Proteomics announces the availability of three new biomarker panels to further explore the complexities of the human proteome 22
Sep 21, 2016: Olink Proteomics announces the availability of the broadest and most complete protein biomarker panel for immuno-oncology 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24
List of Tables
Olink Proteomics AB, Medical Equipment, Key Facts 2
Olink Proteomics AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Olink Proteomics AB, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Olink Proteomics AB, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Olink Proteomics AB, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Olink Proteomics AB, Deals By Market, 2011 to YTD 2017 8
Olink Proteomics AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Olink Secures Venture Financing 10
Fluidigm Enters Into Co-Marketing Agreement With Olink Bioscience For Protein Biomarkers 11
Sigma Life Science Enters Into Distribution Agreement With Olink Bioscience For Duolink Technology 13
Olink Bioscience Enters Into Distribution Agreement With Bethyl Labs 14
Sigma-Aldrich Acquires Duolink Product Portfolio from Olink Bioscience 15
Olink Proteomics AB, Key Competitors 16
Olink Proteomics AB, Key Employees 17
Olink Proteomics AB, Other Locations 18
Olink Proteomics AB, Subsidiaries 18